Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line

Clin Biochem. 2012 Nov;45(16-17):1519-21. doi: 10.1016/j.clinbiochem.2012.06.032. Epub 2012 Jul 6.

Abstract

Objectives: This study aimed at exploring the role of curcumin and taurine alone or in combination against cultured human hepatoma cells (Huh-7 cells).

Design and methods: Huh-7 cells were plated and treated with various concentrations of curcumin and/or taurine. Hemocytometer cell count, cell viability, quantification of γ-IFN concentrations, and flow cytometric analyses for CD4, CD8, and CD25 were carried out.

Results: There were significant increases in the levels of cell density, γ-IFN, and CD8, accompanied with significant decrease in the level of CD4, when comparing cultured cells treated with curcumin and taurine with control cultured cells.

Conclusion: Curcumin/taurine in combination formula is better treatment than single therapy, with respect to cell density and γ-IFN. Moreover, curcumin/taurine combined therapy enhances immunity by stimulating the CD4(+) T-helper cells with consequent induction of CD8 T-cell responses to lyse tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • CD4 Antigens / metabolism
  • CD8 Antigens / metabolism
  • Carcinoma, Hepatocellular
  • Cell Line, Tumor
  • Cell Proliferation
  • Curcumin / pharmacology*
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-2 Receptor alpha Subunit / metabolism
  • Liver Neoplasms
  • Taurine / pharmacology*

Substances

  • Antineoplastic Agents
  • CD4 Antigens
  • CD8 Antigens
  • IL2RA protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Taurine
  • Interferon-gamma
  • Curcumin